中文(简体)
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Observational Study With PASCALLERG ® in Patients With Hay Fever

只有注册用户可以翻译文章
登陆注册
链接已保存到剪贴板
状态已完成
赞助商
Pascoe Pharmazeutische Praeparate GmbH

关键词

抽象

The aim of this observational study is to document the therapeutic use of PASCALLERG ® for hay fever. Based on the survey is a decrease in disease-specific symptoms when taking PASCALLERG ® over a period of 4 weeks will be documented. In addition to the compatibility can be assessed.

描述

There are documented male and female patients over the age of one year who suffer from hay fever. The traetment time is about a period of 4 weeks with PASCALLERG® tablets.

日期

最后验证: 03/31/2017
首次提交: 07/31/2012
提交的预估入学人数: 08/05/2012
首次发布: 08/08/2012
上次提交的更新: 04/03/2017
最近更新发布: 06/18/2017
首次提交结果的日期: 04/20/2016
首次提交质量检查结果的日期: 04/03/2017
首次发布结果的日期: 06/18/2017
实际学习开始日期: 01/31/2012
预计主要完成日期: 06/30/2013
预计完成日期: 06/30/2013

状况或疾病

Hay Fever

-

手臂组

干预/治疗
PASCALLERG® tablets in patients with hay fever
Patients with lactose intolerance and / or chromium hypersensitivity are excluded from the observational study.

资格标准

有资格学习的年龄 1 Year 至 1 Year
有资格学习的性别All
取样方式Probability Sample
接受健康志愿者
标准

Inclusion Criteria:

- hay fever

Exclusion Criteria:

- Lactose intolerance and / or

- Chromium hypersensitivity

结果

主要结果指标

1. Efficacy of Pascallerg [appr. 4 weeks after baseline (after appr. 4 weeks of treatment)]

Request of Efficacy using a 4-stage scale (very good efficacy, good efficacy, moderate efficacy, no efficacy)

2. Tolerability [app. 4 weeks after baseline (treatment app. for 4 weeks)]

Request of Tolerability using a 2-stage scale (very good tolerability, bad tolerability)

次要成果指标

1. Numerical Rating Scale Well Beeing (Pre- Post) [Change from Baseline (before treatment; week 0) to last visit (end of observation- approx. 4 weeks after baseline)]

Influence of allergy on the general well-being (scale from 0-no influence to 10 strong influence)

2. Change of Symptom Dry Eyes (Pre- Post) [Change from Baseline (before treatment; week 0) to last visit (end of observation- approx. 4 weeks after baseline)]

Request Scale (0=not present, 1=mild, 2=moderate, 3=strong)

3. Change of Symptom Itching Eyes (Pre- Post) [Change from Baseline (before treatment; week 0) to last visit (end of observation- approx. 4 weeks after baseline)]

Request Scale (0=not present, 1=mild, 2=moderate, 3=strong)

4. Change of Symptom Burning Eyes (Pre-post) [Change from Baseline (before treatment; week 0) to last visit (end of observation- approx. 4 weeks after baseline)]

Request Scale (0=not present, 1=mild, 2=moderate, 3=strong)

5. Change of Symptom Bronchial Complaints (Pre-post) [Change from Baseline (before treatment; week 0) to last visit (end of observation- approx. 4 weeks after baseline)]

Request Scale (0=not present, 1=mild, 2=moderate, 3=strong)

6. Change of Symptom Sneezing (Pre-post) [Change from Baseline (before treatment; week 0) to last visit (end of observation- approx. 4 weeks after baseline)]

Request Scale (0=not present, 1=mild, 2=moderate, 3=strong)

7. Change of Symptom Rhinitis (Pre-post) [Change from Baseline (before treatment; week 0) to last visit (end of observation- approx. 4 weeks after baseline)]

Request Scale (0=not present, 1=mild, 2=moderate, 3=strong)

8. Change of Symtom Fatigue / Tiredness [Change from Baseline (before treatment; week 0) to last visit (end of observation- approx. 4 weeks after baseline)]

Request Scale (0=not present, 1=mild, 2=moderate, 3=strong)

9. Change of Symptom Headache (Pre-post) [Change from Baseline (before treatment; week 0) to last visit (end of observation- approx. 4 weeks after baseline)]

Request Scale (0=not present, 1=mild, 2=moderate, 3=strong)

10. Change of Symptom Tearing Eyes (Pre-post) [Change from Baseline (before treatment; week 0) to last visit (end of observation- approx. 4 weeks after baseline)]

Request Scale (0=not present, 1=mild, 2=moderate, 3=strong)

加入我们的脸书专页

科学支持的最完整的草药数据库

  • 支持55种语言
  • 科学支持的草药疗法
  • 通过图像识别草药
  • 交互式GPS地图-在位置标记草药(即将推出)
  • 阅读与您的搜索相关的科学出版物
  • 通过药效搜索药草
  • 组织您的兴趣并及时了解新闻研究,临床试验和专利

输入症状或疾病,并阅读可能有用的草药,输入草药并查看所使用的疾病和症状。
*所有信息均基于已发表的科学研究

Google Play badgeApp Store badge